Abstract:Infection of multidrug-resistant (MDR) bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA), carbapenem-resistant Enterobacteriaceae (CRE), and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli, brings public health issues and causes economic burden. Pathogenic bacteria develop several methods to resist antibiotic killing or inhibition, such as mutation of antibiotic function sites, activation of drug efflux pumps, and enzyme-mediated drug degradation. Antibiotic resistance components can be transferred between bacteria by mobile genetic elements including plasmids, transposons, and integrons, as well as bacteriophages. The development of antibiotic resistance limits the treatment options for bacterial infection, especially for MDR bacteria. Therefore, novel or alternative antibacterial agents are urgently needed. Antimicrobial peptides (AMPs) display multiple killing mechanisms against bacterial infections, including directly bactericidal activity and immunomodulatory function, as potential alternatives to antibiotics. In this review, the development of antibiotic resistance, the killing mechanisms of AMPs, and especially, the design, optimization, and delivery of AMPs are reviewed. Strategies such as structural change, amino acid substitution, conjugation with cell-penetration peptide, terminal acetylation and amidation, and encapsulation with nanoparticles will improve the antimicrobial efficacy, reduce toxicity, and accomplish local delivery of AMPs. In addition, clinical trials in AMP studies or applications of AMPs within the last five years were summarized. Overall, AMPs display diverse mechanisms of action against infection of pathogenic bacteria, and future research studies and clinical investigations will accelerate AMP application.

Antimicrobial Peptides: Mechanism, Expressions, and Optimization Strategies

Advances in microbial antimicrobial peptides expression system and transformation strategy

Antimicrobial Peptides: Design, Chemical Synthesis, Activity Evaluation, and Application

Heterologous Production of Antimicrobial Peptides: Notes to Consider

Antimicrobial peptides: Promising alternatives in the post feeding antibiotic era

Antimicrobial peptides: mechanism of action, activity and clinical potential

[Progress on the design and optimization of antimicrobial peptides]

The Modification and Design of Antimicrobial Peptide.

Chemical modifications to increase the therapeutic potential of antimicrobial peptides

Development strategies and application of antimicrobial peptides as future alternatives to in-feed antibiotics

Antimicrobial Peptides: The Production of Novel Peptide-Based Therapeutics in Plant Systems

Design methods for antimicrobial peptides with improved performance

Embracing the era of antimicrobial peptides with marine organisms

Antimicrobial Peptides: From Design to Clinical Application

Using chemical synthesis to optimise antimicrobial peptides in the fight against antimicrobial resistance

Antimicrobial Peptides: Recent Insights on Biotechnological Interventions and Future Perspectives

Molecular farming for sustainable production of clinical‐grade antimicrobial peptides

Recent Advances on Antimicrobial Peptides from Milk: Molecular Properties, Mechanisms, and Applications

Integrated computational approaches for advancing antimicrobial peptide development

Mechanisms of Action, Biological Characteristics, and Future Prospects: A Review of Antimicrobial Peptides (A Review)

Antimicrobial Peptides as Effective Agents Against Drug-Resistant Pathogens